Your session is about to expire
← Back to Search
Digital Behavioral Therapy for Insomnia (dBTS Trial)
dBTS Trial Summary
This trial is testing an internet-based version of cognitive-behavioral therapy for insomnia (CBT-I) against sleep hygiene education (SHE) in 60 HIV-positive patients with insomnia. The goal is to see if dCBTI or SHE improves insomnia in this patient group.
dBTS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.dBTS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are at high risk of having trouble breathing while sleeping.You have been diagnosed with restless legs syndrome.You are 18 years old or older.You are currently getting help for trouble sleeping from a psychologist or counselor.You have been diagnosed with insomnia disorder according to the DSM-5.You are currently having thoughts about hurting yourself.
- Group 1: Digital cognitive-behavioral therapy for insomnia (dCBTI)
- Group 2: Sleep hygiene education (SHE)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for participants to enroll in this research experiment?
"According to the clinicaltrials.gov database, this specific trial is no longer recruiting participants; it was initially posted on March 1st 2020 and last updated on May 17th 2022. However, there are still 228 other trials looking for volunteers at present time."
What aims are being pursued through the implementation of this clinical experiment?
"The chief goal of this medical trial, which is adjudicated over a period spanning 24 weeks and assessed at various intervals, will be to measure changes in sleep efficiency. Secondary ambitions include observing alterations in total sleep time (TST), transfigurations in depressive symptoms as recorded on the Center for Epidemiologic Studies Depression Scale (CES-D) - scores range from 0 to 60 with higher numbers indicating greater severity - and shifts observed through Snaith-Hamilton Pleasure Scale (SHAPS) measurements; here too, scores generally run between 0 and 14 where higher readings indicate a poorer outcome."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger